By Jasmin Herrera
NC Business News Wire
Asklepios BioPharmaceutical Inc., better known as AskBio, has received a $235 million investment to augment and accelerate growth of its business.
The company partnered with TPG Capital, an alternative asset group that has invested in Airbnb and Spotify, and Vida Ventures, a life sciences investment firm, to make up the lump sum of the financing.
AskBio specializes in providing gene therapy services for “underserved patient populations with rare and generally untreatable genetic disorders.”
AskBio stated that the investment will help the company drive long-term growth by providing additional capital to enhance manufacturing capabilities and capacities and to advance and expand clinical trials.
Read the full story via the North Carolina Business News Wire, a service of the UNC-Chapel Hill School of Media and Journalism.
| UNC-CH
